Lumos Diagnostics, Inc.

Lumos Diagnostics is an ASX-listed developer, manufacturer, and distributor of point-of-care diagnostic technologies that deliver rapid, cost-effective diagnostic test solutions for healthcare professionals. The company specializes in rapid blood-based diagnostic assays and proprietary digital reader platforms that enable real-time assessment and differentiation of medical conditions at the point-of-care. FebriDx® is their flagship product—a rapid fingerstick blood test that aids differentiation between bacterial and non-bacterial infections, supporting clinical decision-making around antibiotic use. The company also offers ViraDx and reader platforms. Beyond proprietary products, Lumos provides comprehensive contract development and manufacturing services including strategic innovation and assay development, product development and manufacturing transfer using Lumos technology platforms, clinical and product validation, and commercial-scale manufacture of test strips and digital readers. Their in-house qualified team supports all stages from concept through commercialization, including medical, quality, and regulatory affairs. The US headquarters is located in Carlsbad, California, with a corporate office in Melbourne, Australia. Lumos serves global markets through qualified clinicians, healthcare systems, and diagnostic product manufacturers seeking custom point-of-care diagnostic solutions.